Sizwe CRS

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• HIV2 trials
• Tuberculosis2 trials

Phase

• Phase 1/22 trials

Status

• Completed2 trials

Lead sponsor

• National Institute of Allergy and Infectious Diseases (NIAID)2 trials

Closed trials

• Completed

  Evaluating the Pharmacokinetics, Safety, and Tolerability of Delamanid in Combination With Optimized Multidrug Background Regimen (OBR) for Multidrug-Resistant Tuberculosis (MDR-TB) in Children With MDR-TB With and Without HIV

  NCT03141060· Phase 1/2· National Institute of Allergy and Infectious Diseases (NIAID)· Source

• Completed

  Evaluating the Pharmacokinetics, Safety, and Tolerability of Bedaquiline in Infants, Children, and Adolescents With Multidrug-Resistant Tuberculosis, Living With or Without HIV

  NCT02906007· Phase 1/2· National Institute of Allergy and Infectious Diseases (NIAID)· Source